Novavax Inc. closed 60.47% below its 52-week high of $17.81, which the company achieved on July 26th.

Moderna’s cash flow issues are more immediate than those of its peers, so the new provision could have a greater impact on ...

Jeneen Interlandi, a domestic correspondent for Opinion and a staff writer at the magazine, writes frequently about public health. For this article, she interviewed dozens of people who have worked ...

Moderna shares surged 9.5% amid legal backlash against vaccine policy changes. Will it be a turning point for MRNA which is ...

Major health groups sue HHS and Robert F. Kennedy Jr. over COVID-19 vaccine policy changes for children and pregnant ...